Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Balzarini

Showing results (31-40 of 672) with videos related to

Pageof 68
Sort By:
Journal of Medicinal Chemistry|October 7, 2008
Studies on enzyme-cleavable dialkoxymethyl-cyclosaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphatesNicolas Gisch, Jan Balzarini, Chris Meier
Medicinal Research Reviews|July 14, 2006
The regulation of HIV-1 transcription: molecular targets for chemotherapeutic interventionMiguel Stevens, Erik De Clercq, Jan Balzarini
Antiviral Chemistry & Chemotherapy|January 15, 2011
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acidsPaul C Trippier, Jan Balzarini, Christopher McGuigan
EXCLI Journal|September 30, 2015
Mycoplasmas and cancer: focus on nucleoside metabolismJohan Vande Voorde, Jan Balzarini, Sandra Liekens
Antiviral Chemistry & Chemotherapy|August 17, 2010
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: monophenylboronic acidsPaul C Trippier, Christopher McGuigan, Jan Balzarini
Nucleosides, Nucleotides & Nucleic Acids|July 11, 2014
Novel 5-arylcarbamoyl-2-methylisoxazolidin-3-yl-3-phosphonates as nucleotide analoguesKamil Kokosza, Jan Balzarini, Dorota G Piotrowska
Journal of the American Chemical Society|May 19, 2005
The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulationsFátima Rodríguez-Barrios, Jan Balzarini, Federico Gago
Bioorganic & Medicinal Chemistry|February 6, 2013
Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a carbamoyl linkerKamil Kokosza, Jan Balzarini, Dorota G Piotrowska
Journal of Medicinal Chemistry|August 10, 2017
The ProTide Prodrug Technology: From the Concept to the ClinicYoucef Mehellou, Hardeep S Rattan, Jan Balzarini
Journal of Medicinal Chemistry|October 16, 2010
Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphateCristina Arbelo Roman, Jan Balzarini, Chris Meier
Pageof 68

Showing results (31-40 of 672) with videos related to

Sort By:
Pageof 68
Journal of Medicinal Chemistry|October 7, 2008
Studies on enzyme-cleavable dialkoxymethyl-cyclosaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphatesNicolas Gisch, Jan Balzarini, Chris Meier
Medicinal Research Reviews|July 14, 2006
The regulation of HIV-1 transcription: molecular targets for chemotherapeutic interventionMiguel Stevens, Erik De Clercq, Jan Balzarini
Antiviral Chemistry & Chemotherapy|January 15, 2011
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acidsPaul C Trippier, Jan Balzarini, Christopher McGuigan
EXCLI Journal|September 30, 2015
Mycoplasmas and cancer: focus on nucleoside metabolismJohan Vande Voorde, Jan Balzarini, Sandra Liekens
Antiviral Chemistry & Chemotherapy|August 17, 2010
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: monophenylboronic acidsPaul C Trippier, Christopher McGuigan, Jan Balzarini
Nucleosides, Nucleotides & Nucleic Acids|July 11, 2014
Novel 5-arylcarbamoyl-2-methylisoxazolidin-3-yl-3-phosphonates as nucleotide analoguesKamil Kokosza, Jan Balzarini, Dorota G Piotrowska
Journal of the American Chemical Society|May 19, 2005
The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulationsFátima Rodríguez-Barrios, Jan Balzarini, Federico Gago
Bioorganic & Medicinal Chemistry|February 6, 2013
Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a carbamoyl linkerKamil Kokosza, Jan Balzarini, Dorota G Piotrowska
Journal of Medicinal Chemistry|August 10, 2017
The ProTide Prodrug Technology: From the Concept to the ClinicYoucef Mehellou, Hardeep S Rattan, Jan Balzarini
Journal of Medicinal Chemistry|October 16, 2010
Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphateCristina Arbelo Roman, Jan Balzarini, Chris Meier
Pageof 68